关闭
 
读者在线:用户名 密码
首页 期刊简介 投稿须知 期刊目录 专家风采 编委会 特邀顾问 联系我们 移动出版
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5



刊物信息

期刊名称:药物分析杂志
主管单位:中国科学技术协会
主办单位:中国药学会
承办:中国食品药品检定研究院
主编:金少鸿
地址:北京天坛西里2号
邮政编码:100050
电话:010-67012819,67058427
电子邮箱:ywfx@nifdc.org.cn
国际标准刊号:ISSN 0254-1793
国内统一刊号:CN 11-2224/R
邮发代号:2-237
 

访问统计
您是第  1 2 3 4 0 8 8 8 位浏览者
您当前的位置:首页 >> 正文

亲水作用色谱串联质谱法测定人血浆中的拉米夫定

Determination of lamivudine in human plasma by hydrophilic interaction chromatography (HILIC) tandem mass spectrometry

分类号:
出版年·卷·期(页码):2011,31 (8):0-0
DOI: 10.16155/j.0254-1793.2017.01.01
-----摘要:-------------------------------------------------------------------------------------------

<p><b>目的: </b>建立简便、快速的亲水作用色谱串联质谱法(HILIC-MS/MS)测定人血浆中的拉米夫定。 <b>方法: </b>以<sup>13</sup>C<sub>1</sub>,<sup>15</sup>N<sub>2</sub>(拉米夫定为内标,血浆样品经乙腈沉淀蛋白后,采用Luna HILIC(100 mm&times;3.0 mm,3 &mu;m)柱分离。流动相为乙腈-5 mmol&middot;L<sup>-1</sup>醋酸铵-甲酸(95∶ 5∶ 0.01,<em>v/v/v</em>),进样体积2 &mu;L,样品分析时间3 min。采用ESI源正离子模式、多反应监测(MRM),用于定量分析的离子反应分别为<em>m/z</em> 230 (112(拉米夫定)和<em>m/z</em> 233 (115(内标)。 <b>结果: </b>测定人血浆中拉米夫定的线性范围为8.0~2000 ng&middot;mL<sup>-1</sup>,定量下限为8.0 ng&middot;mL<sup>-1</sup>,日内、日间精密度(RSD)均小于9.0%,准确度(RE)在-7.1%~2.7%之间。本法成功应用于健康受试者口服2种拉米夫定片后的生物等效性研究。 <b>结论: </b>采用稳定同位素内标的HILIC-MS/MS法更为简便、快捷和准确,适用于人血浆样品中拉米夫定的测定。</p>

-----英文摘要:---------------------------------------------------------------------------------------

<p><b>Objective: </b>To develop and validate a hydrophilic interaction chromatography-tandem mass spectrometric (HILIC-MS/MS) method for the determination of lamivudine in human plasma. <b>Method: </b>The plasma sample was protein precipitated with acetonitrile using the stable labelled <sup>13</sup>C<sub>1</sub>,<sup>15</sup>N<sub>2</sub>-lamivudine as the internal standard.After sample preparation,the analyte and the IS were separated on a Luna HILIC(100 mm&times;3.0 mm,3 &mu;m)column using 2 &mu;L injection volume with a run time of 3.0 min.The mobile phase consisited of acetonitrile-5 mmol&middot;L<sup>-1</sup> ammonium acetate-formic acid (95∶ 5∶ 0.01,<em>v/v/v</em>).Detection was performed by tandem mass spectrometry using an electrosprasy source (ESI) in the positive ion mode,operating in the multiple reaction monitoring (MRM) of the transitions of <em>m/z</em> 230&rarr;112 and <em>m/z</em> 233&rarr;115 for lamivudine and the IS,respectively. <b>Results: </b>The linear calibration curves were obtained in the concentration range of 8.0-2000 ng&middot;mL<sup>-1</sup>.The lower limit of quantification was 8.0 ng&middot;mL<sup>-1</sup>.The intra-day and inter-day relative standard deviation over the entire concentration range was less than 9.0%.The accuracy was in the range of-7.1% to 2.7% in terms of relative error.The method was applied to evaluate the bioequivalence of two lamivudine tablet formulations in healthy volunteers. <b>Conclusion: </b>This method is simple,selective,rapid and suitable for the determination of lamivudine in human plasma.</p>

-----参考文献:---------------------------------------------------------------------------------------

欢迎阅读《药物分析杂志》!您是该文第 1419位读者!

药物分析杂志 © 2009
地址:北京天坛西里2号 邮政编码:100050; 电子邮件:ywfx@nicpbp.org.cn